Hugo T, Harper AR, Leander J, Gardiner P, et al. Elarekibep, an inhaled anti-IL-4 receptor alpha Anticalin, in moderate-to-severe asthma: a randomized, placebo-controlled phase 2a study (APATURA). Respir Res 2026 Apr 14. doi: 10.1186/s12931-026-03613.
PMID: 41981420